U.S. markets close in 2 hours 37 minutes

1Life Healthcare, Inc. (ONEM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
30.78-1.13 (-3.54%)
As of 1:23PM EDT. Market open.
Full screen
Loading interactive chart...
  • GlobeNewswire

    1Life Healthcare (One Medical) Announces Date of its Third Quarter 2020 Results Conference Call

    SAN FRANCISCO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that its third quarter 2020 results will be released on Tuesday, November 10, 2020, after the close of the market. The company will host a conference call on the same day at 1:30 p.m. (PT) / 4:30 p.m. (ET) to discuss its financial results. A live audio webcast will be available online at https://investor.onemedical.com. The conference call can also be accessed by dialing 1-800-258-1651 for U.S. participants, or 1-612-979-9928 for international participants, and referencing conference ID 2117769. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.About One Medical One Medical is a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. Our vision is to delight millions of members with better health and better care while reducing costs. Our mission is to transform health care for all through our human-centered, technology-powered model.Headquartered in San Francisco, 1Life Healthcare, Inc. is the administrative and managerial services company for the affiliated One Medical physician owned professional corporations that deliver medical services in-office and virtually. 1Life and the One Medical entities do business under the “One Medical” brand.Investor Contact: Rose Salzwedel, One Medical Director of Investor Relations investor@onemedical.com 206-331-2211Media Contact: Kristina Skinner, One Medical Director of External Communications press@onemedical.com 650-743-5187

  • Benzinga

    Benzinga's Top Upgrades, Downgrades For October 14, 2020

    Upgrades * For AnaptysBio Inc (NASDAQ: ANAB), Guggenheim upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, AnaptysBio showed an EPS of $0.79, compared to $0.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of 39.48 and a 52-week-low of 10.0. AnaptysBio closed at $17.76 at the end of the last trading period. * According to Loop Capital, the prior rating for American Eagle Outfitters Inc (NYSE: AEO) was changed from Sell to Hold. In the second quarter, American Eagle Outfitters showed an EPS of $0.03, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of 16.825 and a 52-week-low of 6.535. American Eagle Outfitters closed at $14.80 at the end of the last trading period. * According to UBS, the prior rating for Workday Inc (NASDAQ: WDAY) was changed from Sell to Neutral. In the second quarter, Workday showed an EPS of $0.84, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of 248.75 and a 52-week-low of 107.75. At the end of the last trading period, Workday closed at $232.90. * For AutoZone Inc (NYSE: AZO), Raymond James upgraded the previous rating of Outperform to the current rating Strong Buy. AutoZone earned $30.93 in the fourth quarter, compared to $20.95 in the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of 1274.4075 and a 52-week-low of 684.91. Moreover, at the end of the last trading period, the closing price was at $1165.71. * JP Morgan upgraded the previous rating for NIO Inc (NYSE: NIO) from Neutral to Overweight. NIO earned $0.15 in the second quarter, compared to $0.45 in the year-ago quarter. The current stock performance of NIO shows a 52-week-high of 22.59 and a 52-week-low of 1.36. Moreover, at the end of the last trading period, the closing price was at $21.61. * According to Jefferies, the prior rating for Beacon Roofing Supply Inc (NASDAQ: BECN) was changed from Hold to Buy. For the third quarter, Beacon Roofing Supply had an EPS of $1.01, compared to year-ago quarter EPS of $0.32. The stock has a 52-week-high of 37.06 and a 52-week-low of 11.665. At the end of the last trading period, Beacon Roofing Supply closed at $35.43. * For Theravance Biopharma Inc (NASDAQ: TBPH), Morgan Stanley upgraded the previous rating of Equal-Weight to the current rating Overweight. Theravance Biopharma earned $1.00 in the second quarter, compared to $0.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of 31.54 and a 52-week-low of 14.48. Theravance Biopharma closed at $17.28 at the end of the last trading period. Downgrades * B of A Securities downgraded the previous rating for Paramount Group Inc (NYSE: PGRE) from Neutral to Underperform. In the second quarter, Paramount Group showed an EPS of $0.23, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of 15.0 and a 52-week-low of 6.42. Paramount Group closed at $7.00 at the end of the last trading period. * According to UBS, the prior rating for Splunk Inc (NASDAQ: SPLK) was changed from Buy to Sell. For the second quarter, Splunk had an EPS of $0.33, compared to year-ago quarter EPS of $0.67. At the moment, the stock has a 52-week-high of 225.8944 and a 52-week-low of 93.92. Splunk closed at $215.83 at the end of the last trading period. * For Constellation Brands Inc (NYSE: STZ), Atlantic Equities downgraded the previous rating of Overweight to the current rating Neutral. For the second quarter, Constellation Brands had an EPS of $2.76, compared to year-ago quarter EPS of $2.72. At the moment, the stock has a 52-week-high of 208.55 and a 52-week-low of 104.28. Constellation Brands closed at $187.57 at the end of the last trading period. * According to JP Morgan, the prior rating for Invitae Corp (NYSE: NVTA) was changed from Overweight to Neutral. For the second quarter, Invitae had an EPS of $0.77, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of 55.38 and a 52-week-low of 7.415. At the end of the last trading period, Invitae closed at $52.59. * For Livongo Health Inc (NASDAQ: LVGO), JP Morgan downgraded the previous rating of Overweight to the current rating Neutral. In the second quarter, Livongo Health showed an EPS of $0.11, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of 151.049 and a 52-week-low of 17.25. At the end of the last trading period, Livongo Health closed at $148.08. * For Albemarle Corp (NYSE: ALB), RBC Capital downgraded the previous rating of Sector Perform to the current rating Underperform. For the second quarter, Albemarle had an EPS of $0.86, compared to year-ago quarter EPS of $1.55. At the moment, the stock has a 52-week-high of 101.0 and a 52-week-low of 48.8901. Albemarle closed at $95.10 at the end of the last trading period. * KeyBanc downgraded the previous rating for Pentair PLC (NYSE: PNR) from Overweight to Sector Weight. For the second quarter, Pentair had an EPS of $0.59, compared to year-ago quarter EPS of $0.69. At the moment, the stock has a 52-week-high of 50.52 and a 52-week-low of 22.01. Pentair closed at $49.28 at the end of the last trading period. Initiations * With a current rating of Equal-Weight, Stephens & Co. initiated coverage on West Pharmaceutical Services Inc (NYSE: WST). The price target seems to have been set at $300.00 for West Pharmaceutical Servs. For the second quarter, West Pharmaceutical Servs had an EPS of $1.25, compared to year-ago quarter EPS of $0.89. The current stock performance of West Pharmaceutical Servs shows a 52-week-high of 303.14 and a 52-week-low of 124.53. Moreover, at the end of the last trading period, the closing price was at $299.45. * With a current rating of Buy, Citigroup initiated coverage on PNM Resources Inc (NYSE: PNM). The price target seems to have been set at $51.00 for PNM Resources. In the second quarter, PNM Resources showed an EPS of $0.55, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of 56.14 and a 52-week-low of 27.08. PNM Resources closed at $45.50 at the end of the last trading period. * With a current rating of Buy, Deutsche Bank initiated coverage on 1Life Healthcare Inc (NASDAQ: ONEM). The price target seems to have been set at $37.00 for 1Life Healthcare. 1Life Healthcare earned $0.24 in the second quarter. The current stock performance of 1Life Healthcare shows a 52-week-high of 44.87 and a 52-week-low of 15.0. Moreover, at the end of the last trading period, the closing price was at $29.70. * UBS initiated coverage on VMware Inc (NYSE: VMW) with a Neutral rating. The price target for VMware is set to $155.00. VMware earned $1.81 in the second quarter, compared to $1.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of 173.37 and a 52-week-low of 86.0. VMware closed at $155.04 at the end of the last trading period. * UBS initiated coverage on Veeva Systems Inc (NYSE: VEEV) with a Sell rating. The price target for Veeva Systems is set to $225.00. For the second quarter, Veeva Systems had an EPS of $0.72, compared to year-ago quarter EPS of $0.55. At the moment, the stock has a 52-week-high of 312.0 and a 52-week-low of 118.11. Veeva Systems closed at $308.84 at the end of the last trading period. * UBS initiated coverage on Oracle Corp (NYSE: ORCL) with a Neutral rating. The price target for Oracle is set to $62.00. For the first quarter, Oracle had an EPS of $0.93, compared to year-ago quarter EPS of $0.81. At the moment, the stock has a 52-week-high of 62.5999 and a 52-week-low of 39.71. Oracle closed at $60.97 at the end of the last trading period. * Morgan Stanley initiated coverage on New York Times Co (NYSE: NYT) with an Overweight rating. The price target for New York Times is set to $55.00. In the second quarter, New York Times showed an EPS of $0.18, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of 47.95 and a 52-week-low of 26.13. New York Times closed at $43.41 at the end of the last trading period. * For Intellia Therapeutics Inc (NASDAQ: NTLA), Wells Fargo initiated coverage, by setting the current rating at Overweight. Intellia Therapeutics earned $0.61 in the second quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of 26.77 and a 52-week-low of 9.18. Intellia Therapeutics closed at $24.61 at the end of the last trading period. * UBS initiated coverage on ServiceNow Inc (NYSE: NOW) with a Buy rating. The price target for ServiceNow is set to $600.00. In the second quarter, ServiceNow showed an EPS of $1.23, compared to $0.71 from the year-ago quarter. The stock has a 52-week-high of 522.77 and a 52-week-low of 213.99. At the end of the last trading period, ServiceNow closed at $518.22. * HC Wainwright & Co. initiated coverage on Compass Pathways PLC (NASDAQ: CMPS) with a Buy rating. The price target for Compass Pathways is set to $65.00. The current stock performance of Compass Pathways shows a 52-week-high of 47.29 and a 52-week-low of 22.51. Moreover, at the end of the last trading period, the closing price was at $38.82. * With a current rating of Outperform, CICC initiated coverage on Niu Technologies (NASDAQ: NIU). The price target seems to have been set at $31.00 for Niu Technologies. In the second quarter, Niu Technologies showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of 28.4899 and a 52-week-low of 6.08. At the end of the last trading period, Niu Technologies closed at $27.37. * UBS initiated coverage on Microsoft Corp (NASDAQ: MSFT) with a Buy rating. The price target for Microsoft is set to $243.00. For the fourth quarter, Microsoft had an EPS of $1.46, compared to year-ago quarter EPS of $1.37. At the moment, the stock has a 52-week-high of 232.86 and a 52-week-low of 132.52. Microsoft closed at $222.86 at the end of the last trading period. * UBS initiated coverage on DocuSign Inc (NASDAQ: DOCU) with a Buy rating. The price target for DocuSign is set to $290.00. For the second quarter, DocuSign had an EPS of $0.17, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of 290.23 and a 52-week-low of 61.68. At the end of the last trading period, DocuSign closed at $238.21. * UBS initiated coverage on Citrix Systems Inc (NASDAQ: CTXS) with a Neutral rating. The price target for Citrix Systems is set to $146.00. For the second quarter, Citrix Systems had an EPS of $1.53, compared to year-ago quarter EPS of $1.21. At the moment, the stock has a 52-week-high of 173.56 and a 52-week-low of 97.45. Citrix Systems closed at $144.03 at the end of the last trading period. * UBS initiated coverage on Salesforce.com Inc (NYSE: CRM) with a Buy rating. The price target for Salesforce.com is set to $325.00. For the second quarter, Salesforce.com had an EPS of $1.44, compared to year-ago quarter EPS of $0.66. At the moment, the stock has a 52-week-high of 284.5 and a 52-week-low of 115.29. Salesforce.com closed at $266.76 at the end of the last trading period. * With a current rating of Buy, HC Wainwright & Co. initiated coverage on Humanigen Inc (NASDAQ: HGEN). The price target seems to have been set at $31.00 for Humanigen. Humanigen earned $0.16 in the second quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of 33.95 and a 52-week-low of 3.4. Humanigen closed at $12.03 at the end of the last trading period. * With a current rating of Buy, Needham initiated coverage on Calix Inc (NYSE: CALX). The price target seems to have been set at $25.00 for Calix. Calix earned $0.14 in the second quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of 22.69 and a 52-week-low of 5.61. At the end of the last trading period, Calix closed at $19.50. * Wedbush initiated coverage on Unity Software Inc (NYSE: U) with an Outperform rating. The price target for Unity Software is set to $125.00. The current stock performance of Unity Software shows a 52-week-high of 102.63 and a 52-week-low of 65.11. Moreover, at the end of the last trading period, the closing price was at $92.19.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Progressive: Q3 Earnings Insights * Looking Into Concho Resources's Return On Capital Employed(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Hedge Funds Are Nibbling On 1Life Healthcare, Inc. (ONEM)
    Insider Monkey

    Hedge Funds Are Nibbling On 1Life Healthcare, Inc. (ONEM)

    How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]